{"id":2597,"date":"2023-06-22T11:35:46","date_gmt":"2023-06-22T11:35:46","guid":{"rendered":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/?p=2597"},"modified":"2023-06-22T11:36:24","modified_gmt":"2023-06-22T11:36:24","slug":"international-congress-of-the-european-haematology-association-conference-in-frankfurt-germany-june-2023","status":"publish","type":"post","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/international-congress-of-the-european-haematology-association-conference-in-frankfurt-germany-june-2023\/","title":{"rendered":"International Congress of the European Haematology Association Conference in Frankfurt Germany June 2023"},"content":{"rendered":"

International Congress of the European Haematology Association Conference in Frankfurt, Germany \u2013 8th<\/sup>-11th<\/sup> June 2023<\/strong><\/p>\n

With more than 12,000 delegates a year, this conference is the leading meeting place for haematologists in all fields of this speciality in Europe and beyond.\u00a0 The focus for the CTR attendees, (myself, Joanna Canham and Oliver Cumming) was on acute myeloid leukaemia (AML) sessions, which included oral and poster presentations about the Cardiff University-Sponsored AML trials.<\/p>\n

These presentations reflect many years of hard work by the trial teams, not least those named as authors below.<\/p>\n

On Friday 9th<\/sup>, the AML sessions included oral presentations of AML18 (quizartinib experience, presented by Professor Steven Knapper) and AML19 (FLAG-Ida, presented by Professor Nigel Russell).<\/p>\n

\"\"
quizartinib experience, presented by Professor Steven Knapper<\/figcaption><\/figure>\n
\"\"
AML19 (FLAG-Ida, presented by Professor Nigel Russell)<\/figcaption><\/figure>\n

Results from the trials, which are supported by the NCRI AML working group, have always been held in high regard internationally, and the results were very well-received \u2013 the midotarg presentation forms the backbone of a new trial funding application, and the Quizartinib data is already of interest to our pharma collaborator.<\/p>\n

The poster sessions throughout the conference included further presentation of data from AML19 (midotarg follow-up, Cumming, Wilhelm-Benartzi, Batten, Hinson, Canham) and posters below.<\/p>\n

\"\"
Quality of Life data (AML18 and LI1, Gianatsi, Thomas A, Thomas I)<\/figcaption><\/figure>\n
\"\"
AML17\/19 (molecular monitoring, Thomas A, Wilhelm-Benartzi, Johnson, Canham, Thomas I)<\/figcaption><\/figure>\n
\"\"
Ian Thomas<\/figcaption><\/figure>\n

We expect these posters to progress to equally impactful publications as the poster presentations \u2013 in particular, the abstract based on molecular monitoring which included a dedication to the late (great) Professor David Grimwade.<\/p>\n

As ever with conference attendance, the main business was undertaken between meetings, over coffee or evening dinner, dashing between sessions or, most challenging of all, a breakfast symposium.\u00a0 Jo and I were part of a number of promising meetings with pharma companies and international collaborators from Italy, Germany, France, Hong Kong, the US and across the UK.\u00a0 My personal highlight of the conference was a patient advocacy session where an Italian patient representative reminded us all that \u201cI am not my disease, I am me\u201d!\u00a0 His impassioned reference to understanding and communicating the \u2018side-effects\u2019 on a patient\u2019s life rather than just drug-related toxicities was particularly poignant, and thought-provoking.<\/p>\n

So, all in all, a very successful conference.\u00a0 As with most international conferences the time in (often) a new city is book-ended by a very early start and excited fatigue, and a very late finish with a sense of being dipped in coffee for 4 days. And then straight back to tackling the pile-up of emails the next day.<\/p>\n

We will \u2018go again\u2019 though – and the CTR blood cancer group will no doubt be in a strong position to support key presentations at the American Society of Haematology conference in San Diego in December.<\/p>\n

    \n
  • Blog by Ian Thomas<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"International Congress of the European Haematology Association Conference in Frankfurt, Germany \u2013 8th-11th June 2023 With more than 12,000 delegates a year, this conference is the leading meeting place for […]","protected":false},"author":549,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[],"class_list":["post-2597","post","type-post","status-publish","format-standard","hentry","category-events"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7dIou-FT","jetpack-related-posts":[{"id":3021,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/centre-for-trials-research-at-ictmc2024-7th-international-clinical-trials-methodology-conference-ictmc\/","url_meta":{"origin":2597,"position":0},"title":"Centre for Trials Research At #ICTMC2024: 7th International Clinical Trials Methodology Conference (ICTMC)","author":"Helen Stanton","date":"November 26, 2024","format":false,"excerpt":"- Helen Stanton, Waku Maboshe and Fiona Lugg-Widger This year, the bi-annual International Clinical Trials Methodology Conference (ICTMC) was held in the beautiful and historic city of Edinburgh, Scotland. Held at Edinburgh\u2019s International Conference Centre, proceedings took place from the 30th of September to the 3rd of October 2024. The\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"Centre for Trials attendees at ICTMC 2024","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/11\/Photo1-CTR.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/11\/Photo1-CTR.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2024\/11\/Photo1-CTR.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":553,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/uk-society-for-behavioural-medicine-uksbm-12th-annual-conference-in-cardiff\/","url_meta":{"origin":2597,"position":1},"title":"UK Society for Behavioural Medicine (UKSBM): 12th Annual Conference in Cardiff","author":"Mark Kelson","date":"December 14, 2016","format":false,"excerpt":"The 12th UKSBM conference, organised by a team from the South East Wales Trials Unit (SEWTU) based in the Centre for Trials Research at Cardiff University, lead by Dr Rachel McNamara, was a resounding success. The theme chosen for the conference was \u201cComplex interventions in a complex world\u201d reflecting our\u2026","rel":"","context":"In "Behaviour Change"","block_context":{"text":"Behaviour Change","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/behaviour-change\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2016\/12\/BLS3114.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2016\/12\/BLS3114.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2016\/12\/BLS3114.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2016\/12\/BLS3114.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2016\/12\/BLS3114.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":2396,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/centre-for-trials-research-at-ictmc2022-6th-international-clinical-trials-methodology-conference-ictmc\/","url_meta":{"origin":2597,"position":2},"title":"Centre for Trials Research At #ICTMC2022: 6th International Clinical Trials Methodology Conference (ICTMC)","author":"Cheney Drew","date":"October 27, 2022","format":false,"excerpt":"After a Covid related hiatus, so a year later than planned, the bi-annual International Clinical Trials Methodology Conference (ICTMC) was held in the beautiful spa town of Harrogate at the beginning of October 2022. The ICTMC meeting is a great opportunity to learn about all things methodological in the clinical\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2022\/10\/ICTMC-2022.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2749,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/advancements-in-aml-treatment-insights-from-the-aml18-trial\/","url_meta":{"origin":2597,"position":3},"title":"Advancements in AML Treatment: Insights from the AML18 Trial","author":"Richard Haggerty","date":"November 30, 2023","format":false,"excerpt":"A new publication in Blood for the AML18 trial adds to research evidence to help improve patient outcomes. Acute Myeloid Leukemia (AML) represents a significant challenge in cancer care, particularly among adults where it is the most prevalent form of acute leukemia. Characterised by rapid progression, AML demands immediate and\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/11\/AML-Blood-Cancer-Research-Team.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/11\/AML-Blood-Cancer-Research-Team.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/11\/AML-Blood-Cancer-Research-Team.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/11\/AML-Blood-Cancer-Research-Team.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/11\/AML-Blood-Cancer-Research-Team.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/11\/AML-Blood-Cancer-Research-Team.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2481,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/introducing-our-new-honorary-professor-lewis-white\/","url_meta":{"origin":2597,"position":4},"title":"Introducing Our New Honorary Professor Lewis White","author":"Richard Haggerty","date":"February 8, 2023","format":false,"excerpt":"Professor Lewis White recently joined the Centre for Trials Research as an Honorary Professor jointly with the Division of Infection and Immunity at Cardiff University. In the first of two blogs, he discuss his work in fungal infections. Can you tell us about your background and expertise in the field\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/02\/Professor-Lewis-White-scaled.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/02\/Professor-Lewis-White-scaled.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/02\/Professor-Lewis-White-scaled.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/02\/Professor-Lewis-White-scaled.jpeg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/02\/Professor-Lewis-White-scaled.jpeg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2023\/02\/Professor-Lewis-White-scaled.jpeg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1645,"url":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/clinical-trials-as-a-catalyst-for-change-in-the-big-easy-the-40th-society-for-clinical-trials-annual-meeting-new-orleans-usa\/","url_meta":{"origin":2597,"position":5},"title":"Clinical Trials As A Catalyst For Change In The \u2018Big Easy\u2019 \u2013 The 40th Society For Clinical Trials Annual Meeting, New Orleans, USA","author":"Victoria Shepherd","date":"June 13, 2019","format":false,"excerpt":"By Victoria Shepherd and Nigel Kirby A taste of New Orleans At times New Orleans felt very much like Wales\u2026\u2026 wet. However, when the sun came out and the puddles dried up New Orleans was a place full of culture and friendly faces. The French Quarter is a vibrant place\u2026","rel":"","context":"In "Events"","block_context":{"text":"Events","link":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/category\/events\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/06\/New-Orleans-SCT.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/06\/New-Orleans-SCT.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-content\/uploads\/sites\/499\/2019\/06\/New-Orleans-SCT.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"meta_box":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts\/2597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/users\/549"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/comments?post=2597"}],"version-history":[{"count":2,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts\/2597\/revisions"}],"predecessor-version":[{"id":2604,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/posts\/2597\/revisions\/2604"}],"wp:attachment":[{"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/media?parent=2597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/categories?post=2597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cardiff.ac.uk\/centre-for-trials-research\/wp-json\/wp\/v2\/tags?post=2597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}